23andMe Recieves FDA Clearance to Provide Drug Information for Common Cholesterol Medication 23andMe Blog, 27 Oct 2022 The U.S. Food and Drug Administration (FDA) has granted 23andMe 510(k) clearance for its pharmacogenetics report for the…